These findings have raised the concern that patients with hypertension, who are treated with ACE2-modulating drugs like ACE-inhibitors or AT1R-blockers might be at a higher risk for severe COVID-19 infection, since it could alter the entry-way for the virus [48]. Here, ACE2 is linked to hypertensive disorder.